000			02121 a2200637 4500
005			20250513213635.0
264		0	_c20001026
008			200010s 0 0 eng d
022			_a1528-9117
040			_aNLM _beng _cNLM
100	1		_aLongo, D L
245	0	0	_aCombination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study. _h[electronic resource]
260			_bCancer journal (Sudbury, Mass.) _c
300			_a146-50 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBleomycin _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aCytarabine _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoconjugates _xtherapeutic use
650	0	4	_aImmunotoxins _xtherapeutic use
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy
650	0	4	_aLymphoma _xdrug therapy
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aLymphoma, Mantle-Cell _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRicin _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVincristine _xtherapeutic use
700	1		_aDuffey, P L
700	1		_aGribben, J G
700	1		_aJaffe, E S
700	1		_aCurti, B D
700	1		_aGause, B L
700	1		_aJanik, J E
700	1		_aBraman, V M
700	1		_aEsseltine, D
700	1		_aWilson, W H
700	1		_aKaufman, D
700	1		_aWittes, R E
700	1		_aNadler, L M
700	1		_aUrba, W J
773	0		_tCancer journal (Sudbury, Mass.) _gvol. 6 _gno. 3 _gp. 146-50
999			_c10832879 _d10832879